New expensive but disease-modifying treatments are expected to foster Alzheimer’s disease market growth globally, according to a report. The report by GlobalData, a data and analytics company, showed ...

The lifetime risk of dementia after age 55 is about 42% - more than double the risk reported by earlier studies, and one that puts greater urgency on the need to mitigate addressable health problems, ...

Researchers at New York’s Mount Sinai Hospital have developed a cutting-edge AI-powered algorithm which could aid in the ...

Having depression is known to increase a person’s risk of developing dementia, but depression is also an early indicator of ...

Mild chronic small vessel disease, or cerebral small vessel disease (CSVD), is an umbrella term for a range of conditions ...

NDA submitted to U.S. FDA for CAPLYTA® as adjunctive treatment for major depressive disorder; if approved, CAPLYTA® has ...

Gum disease appears to disrupt brain activity, potentially increasing a person’s risk of cognitive decline.People with ...

Preserving levels of brain glucose metabolism can both slow cognitive decline and reduces the risk of conversion to dementia.

Groundbreaking research unveils potential link between cytomegalovirus and Alzheimer's disease, offering new hope for ...

Research reveals how herpes simplex virus-1 may contribute to Alzheimer’s disease, offering new insights into the disease’s ...

Cognitive profiles for early diagnosis of Dementia with Lewy bodies (DLB) have been outlined in a new study, out today in ...